SCHEMBL13592

SCHEMBL13592

Bc1ccc2c(cnn2C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.45
CTNNB1 P35222 1/20 0.43
TCF7 P36402 1/20 0.43
CDC7 O00311 1/20 0.43
TRPM5 Q9NZQ8 1/20 0.43
MAOB P27338 4/20 0.42
APP P05067 1/20 0.41
MAOA P21397 2/20 0.40
ACHE P22303 1/20 0.40
PDE1C Q14123 1/20 0.40
AR P10275 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
RAB9A P51151 1/20 0.39
CYP11B2 P19099 1/20 0.39
CYP1A2 P05177 1/20 0.38
GRM4 Q14833 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16132867 0.84 NOTUM (0.44) CTNNB1TCF7TRPM5PDE1CCYP11B2
SCHEMBL424964 0.78 TRPA1 (0.46) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL29769166 0.78 TRPA1 (0.46) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL13533 0.77 HTR2A (0.43) MAOBMAOAPDE1CCYP1A2
SCHEMBL2117212 0.76 TRPA1 (0.45) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL13106151 0.76 KMO (0.51) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL13106148 0.76 HTR2A (0.53) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL2118942 0.76 MAOB (0.46) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL378619 0.76 CHEK1 (0.57) TRPA1CTNNB1TCF7CDC7TRPM5
SCHEMBL11794 0.76 EGFR (0.46) TRPA1CTNNB1TCF7CDC7TRPM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017078927-A1 ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2017-05-11 WO disclosed
EP-3070081-A1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION Gilead Sciences, Inc. (US) 2016-09-21 EP disclosed
EP-2788336-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2016-03-02 EP disclosed
WO-2015138969-A1 ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2015-09-17 WO disclosed
EP-1997809-B1 P38 inhibitors and methods of use thereof ARRAY BIOPHARMA INC (US) 2014-05-14 EP disclosed
US-20120183563-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE MERCK SHARP & DOHME LLC 2012-07-19 US disclosed
WO-2011044187-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE SCHERING CORPORATION (US) 2011-04-14 WO disclosed
WO-2011020861-A1 HETEROCYCLIC OXIME COMPOUNDS NOVARTIS AG (CH) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120183563-A1 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE BACE1, BACE2, APP TRPA1 2607/4885CTNNB1 26/4885TCF7 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.